Navidea Biopharmaceuticals (NAVB)

Navidea (NAVB) Balance Sheet


Navidea Balance Sheet

Navidea's total assets for Q3 2023 were $5.70M, a decrease of -30.67% from the previous quarter. NAVB total liabilities were $8.68M for the fiscal quarter, a -3.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 4.37M$ 6.43M$ 7.76M$ 4.15M$ 7.02M
Total Liabilities
$ 12.51M$ 6.34M$ 5.71M$ 5.03M$ 4.61M
Total Equity Gross Minority
$ -8.14M$ 624.67K$ 2.05M$ -880.99K$ 2.41M
Total Capitalization
$ -6.02M$ 346.44K$ 1.32M$ -1.61M$ 1.74M
Preferred Stock Equity
--$ 132.00--
Capital Lease Obligations
--$ 590.96K$ 762.90K$ 589.17K
Currency in USD

Navidea Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis